[1]Siegel RL, Miller KD, Fuchs HE, et al.Cancer Statistics, 2021[J].CA Cancer J Clin, 2021,71(1):7-33.
[2]Harbeck N, Gnant M. Breast cancer[J]. Lancet, 2017, 389(10074): 1134-1150.
[3]2020版乳腺癌诊疗指南发布[J].中国肿瘤临床与康复,2020,27(7):884.
[4]中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2019版)[J].中国癌症杂志,2019, 29(8): 609-680.
[5]Magnoni F, Galimberti V, Corso G,et al.Axillary surgery in breast cancer: An updated historical perspective[J].Semin Oncol, 2020, 47(6):341-352.
[6]Mikami Y, Yamada A, Suzuki C,et al.Predicting Nonsentinel Lymph Node Metastasis in Breast Cancer: A Multicenter Retrospective Study[J].J Surg Res, 2021, 264:45-50.
[7]Lyman GH, Somerfield MR, Bosserman LD, et al. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update[J].J Clin Oncol, 2017, 35(5):561-564.
[8]Iancu G, Mustata LM, Cigaran R, et al. Sentinel Lymph Node Biopsy in Breast Cancer. Principle, Difficulties and Pitfalls[J].Chirurgia (Bucur), 2021, 116(5):533-541.
[9]Houvenaeghel G, Lambaudie E, Classe JM, et al. Lymph node positivity in different early breast carcinoma phenotypes: a predictive model[J]. BMC Cancer,2019, 19(1):45.
[10]Li H, Tang L, Chen Y, et al. Development and validation of a nomogram for prediction of lymph node metastasis in early-stage breast cancer[J].Gland Surg, 2021, 10(3):901-913.
[11]Doll KM, Rademaker A, Sosa JA.Practical Guide to Surgical Data Sets: Surveillance, Epidemiology, and End Results (SEER) Database[J].JAMA Surg, 2018, 153(6):588-589.
[12]Killelea BK, Long JB, Dang W, et al.Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ[J].Ann Surg Oncol, 2018, 25(6):1521-1529.
[13]Marino MA, Avendano D, Zapata P, et al.Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools[J].Oncologis, 2020, 25(2):e231-e242.
[14]Rossi L, Mazzara C, Pagani O, et al.Diagnosis and Treatment of Breast Cancer in Young Women[J].Curr Treat Options Oncol, 2019, 27,20(12):86.
[15]Cserni G, Chmielik E, Cserni B, et al. The new TNM-based staging of breast cancer[J].Virchows Arch, 2018, 472(5):697-703.
[16]Amin Mahul B,Greene Frederick L,Edge Stephen B, et al. AJCC Cancer Staging Manual. 8th ed[M]. Springer International Publishing, 2017:619-620.
[17]Tseng HS, Chen LS, Kuo SJ, et al.Tumor characteristics of breast cancer in predicting axillary lymph node metastasis[J].Med Sci Monit, 2014, 20:1155-1161.
[18]Wang R, Zhu Y, Liu X,et al. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer[J].BMC Cancer, 2019, 19(1):1091.
[19]Li X, Yang J, Peng L, et al. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer[J].Breast Cancer Res Treat,2017, 161(2):279-287.
[20]Lin NU, Vanderplas A, Hughes ME, et al. Clinicopathologic features, patterns of recurrence and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network[J]. Cancer, 2012, 118(22): 5463-5472.
[1]徐桂芳,张建东,赵海滨,等.E-钙粘蛋白和MMP-9在胃癌组织中的表达及其临床意义[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):308.
XU Gui-fang,ZHANG Jian-dong,ZHAO Hai-bin,et al.Expression and significance of E-Cadherin and matrix metalloproteinase-9 in gastric carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(4):308.
[2]乐根明,朱燕,陈晨,等.食管癌放疗后局部淋巴结转移行伽马刀治疗联合化疗的疗效分析[J].医学研究与战创伤救治(原医学研究生学报),2017,19(03):268.[doi:10.3969/j.issn.1672-271X.2017.03.012]
YUE Gen-ming,ZHU Yan,CHEN Chen,et al.Clinical analysis on the body gamma knife combined with chemotherapy foresophageal carcinoma complicated with loco-regional lymph node metastasis after radiotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(4):268.[doi:10.3969/j.issn.1672-271X.2017.03.012]